Mumbai, Nov 21st: Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Time Medical, announced a major technological milestone with the launch of VEGA, a highly optimized permanent-magnet MRI system designed specifically for rapid, non-contrast TOF (Time-of-Flight) angiographic screening of unruptured intracranial aneurysms. Developed in close collaboration with Dr. Iype Cherian, a leading neurosurgeon and advocate for population-level screening, VEGA aims to make preventive neurovascular imaging accessible and practical across India.
Transforming Early Detection in India
VEGA’s permanent-magnet, low-field design addresses the key limitations of conventional imaging: it eliminates helium dependency, consumes minimal power, and requires low maintenance. The system delivers high-quality vascular imaging in just six minutes without the use of radiation or contrast agents. By enabling safe, rapid, and non-invasive screening, VEGA allows India to shift from late detection to early intervention, dramatically improving outcomes and reducing aneurysm-related mortality.
Currently, aneurysm detection in India is limited. High-field MRI systems are costly and centralized, while CT angiography involves radiation and contrast, making them unsuitable for mass screening. As a result, most aneurysms are identified only after rupture. By contrast, VEGA is designed for deployment in district hospitals, semi-urban clinics, and mobile diagnostic units, bringing preventive imaging within reach of millions.
Global Evidence Supports Early Screening
Countries such as Japan, the United States, Korea, and European nations have demonstrated that early detection saves lives. Japan’s national “Brain Dock” program, for example, identifies aneurysms in approximately 4.3% of healthy adults, preventing catastrophic ruptures and long-term disability. VEGA brings a similar approach to India, making preventive neurovascular care scalable and sustainable.
AI-Powered Screening at Scale
VEGA integrates modern deep-learning models capable of detecting aneurysms on TOF scans with over 95% sensitivity. Combined with hub-and-spoke teleradiology networks, this allows radiologists to supervise high volumes of studies efficiently, overcoming limitations in specialist availability and enabling nationwide screening at scale.
Statements from Leadership
Dr. Iype Cherian, Neurosurgeon, Parul University, said:
“Aneurysm rupture is one of the most catastrophic neurological events, yet entirely preventable with timely detection. Low-field MRI allows India to move from reactive emergency care to proactive prevention.”
Ms. Svetlana, Director, Time Medical International Ventures (India) Pvt Ltd, added:
“VEGA represents a paradigm shift in preventive neurovascular care. This fully optimized, ready-to-deploy low-field TOF MRI platform delivers rapid, contrast-free vascular imaging at significantly lower operational costs. Its efficiency, affordability, and reliability make it ideal for deployment across district hospitals and semi-urban clinics. With VEGA, we are creating a pathway for earlier detection, proactive brain health, and equitable access to advanced neuro-imaging for communities across India.”
VEGA exemplifies Time Medical India’s commitment to scalable, sustainable, and accessible healthcare innovation, setting a new benchmark for preventive neurovascular diagnostics.